MaxCyte
MXCT
$4.07
Share price
7.30%
Change (1 day)
-35.13%
Change (1 year)
Categories
Revenue for MaxCyte (MXCT)
Revenue in 2024 (TTM): A$58.76 Million
According to MaxCyte's latest financial reports the company's current revenue (TTM 
) is A$62.82 Million. an increase over the revenue in the year 2023 that were of A$60.6 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MaxCyte from 2021 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$62.1 M | 2.48% |
| 2023 | A$60.6 M | -6.83% |
| 2022 | A$65.04 M | 39.12% |
| 2021 | A$46.75 M |